EXANE DERIVATIVES - ICU MED INC ownership

ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ICU MED INC
ValueSharesWeighting
Q2 2022$164,000
-26.5%
10.0%0.00%
Q1 2022$223,000
-5.9%
10.0%0.00%
Q4 2021$237,000
-99.6%
1
-99.6%
0.00%
-100.0%
Q3 2021$52,975,000
-15.1%
227
-25.8%
0.01%
-7.1%
Q2 2021$62,407,000
-75.7%
306
-75.5%
0.01%
-80.8%
Q1 2021$256,994,000
+1.8%
1,251
+6.3%
0.07%
-1.4%
Q4 2020$252,443,000
+190.2%
1,177
+147.3%
0.07%
+196.0%
Q3 2020$86,989,000
+2522.5%
476
+2544.4%
0.02%
+2400.0%
Q2 2020$3,317,000
-96.8%
18
-96.4%
0.00%
-96.6%
Q1 2020$102,293,000
+5748.7%
507
+5533.3%
0.03%
Q4 2019$1,749,000
+174.1%
9
+125.0%
0.00%
Q3 2019$638,000
-36.6%
40.0%0.00%
Q2 2019$1,007,000
+5.2%
40.0%0.00%
Q1 2019$957,000
-99.8%
4
-99.8%
0.00%
-100.0%
Q4 2018$447,410,000
+222.1%
1,949
+300.2%
0.08%
+207.7%
Q3 2018$138,914,000
-2.6%
4870.0%0.03%
+8.3%
Q2 2018$142,558,000
+18.4%
4870.0%0.02%0.0%
Q1 2018$120,438,000
+20.2%
487
+5.0%
0.02%
+41.2%
Q4 2017$100,190,0004640.02%
Other shareholders
ICU MED INC shareholders Q4 2020
NameSharesValueWeighting ↓
EVR Research LP 22,000$4,719,0003.86%
NUANCE INVESTMENTS, LLC 901,483$193,359,0003.73%
Nitorum Capital, L.P. 417,241$89,494,0003.46%
Tamarack Advisers, LP 73,000$15,452,0003.22%
PFM Health Sciences, LP 267,817$57,444,0002.02%
KIRR MARBACH & CO LLC /IN/ 22,222$4,766,0001.49%
PURA VIDA INVESTMENTS, LLC 174,399$37,407,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,584$554,0000.88%
Findlay Park Partners LLP 528,825$113,428,0000.79%
Altium Capital Management LP 9,321$1,999,0000.75%
View complete list of ICU MED INC shareholders